Detalhe da pesquisa
1.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Haematologica
; 109(1): 115-128, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199127
2.
Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry.
Haematologica
; 2024 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38572549
3.
Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry.
Hematol Oncol
; 42(1): e3240, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38050405
4.
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Ann Hematol
; 103(2): 451-461, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110588
5.
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development.
Blood
; 138(17): 1583-1589, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133718
6.
Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival.
Br J Haematol
; 198(2): 278-287, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383901
7.
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
Cancer
; 127(12): 2003-2014, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33626197
8.
Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
Haematologica
; 106(8): 2215-2223, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32675227
9.
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA.
Blood
; 139(10): 1588-1592, 2022 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34748627
10.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Br J Haematol
; 201(6): 1239-1244, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37057357
11.
Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma.
Haematologica
; 102(5): 922-931, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28126960
12.
Blood monitoring of circulating tumor plasma cells by next generation flow in multiple myeloma after therapy.
Blood
; 134(24): 2218-2222, 2019 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31697808
13.
Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization.
Pain Pract
; 16(7): 842-9, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407542
14.
Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant.
Br J Haematol
; 169(5): 719-25, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25817436
15.
A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma.
Acta Oncol
; 54(6): 933-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25734915
16.
ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma.
Ann Hematol
; 93(10): 1745-53, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24863692
17.
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Front Immunol
; 15: 1293931, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38469299
18.
The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey.
Leuk Lymphoma
; 65(2): 199-208, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37966980
19.
Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022.
EClinicalMedicine
; 71: 102553, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38533127
20.
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients.
Haematologica
; 98(3): 437-43, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22899581